| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study
|
Xie, Jie
|
|
2017
|
168 |
2 |
p. 389-399
|
article
|
| 2 |
A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer
|
Ibrahim, Mohammed F. K.
|
|
2017
|
168 |
2 |
p. 371-379
|
article
|
| 3 |
Analysis of breast cancer in young women in the Department of Defense (DOD) database
|
Zimmer, Alexandra S.
|
|
2017
|
168 |
2 |
p. 501-511
|
article
|
| 4 |
A single institution experience with palbociclib toxicity requiring dose modifications
|
Gong, Jun
|
|
2017
|
168 |
2 |
p. 381-387
|
article
|
| 5 |
Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition
|
Santos, E. Santana dos
|
|
2017
|
168 |
2 |
p. 311-325
|
article
|
| 6 |
Associations between ALDH1A1 polymorphisms, alcohol consumption, and mortality among Hispanic and non-Hispanic white women diagnosed with breast cancer: the Breast Cancer Health Disparities Study
|
Xia, Zhiyu
|
|
2017
|
168 |
2 |
p. 443-455
|
article
|
| 7 |
Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy
|
Han, S. N.
|
|
2017
|
168 |
2 |
p. 551-557
|
article
|
| 8 |
CD14+ HLA-DR−/low MDSCs are elevated in the periphery of early-stage breast cancer patients and suppress autologous T cell proliferation
|
Speigl, Lisa
|
|
2017
|
168 |
2 |
p. 401-411
|
article
|
| 9 |
Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy
|
Kwan, Marilyn L.
|
|
2017
|
168 |
2 |
p. 523-530
|
article
|
| 10 |
Characterization of a novel germline BRCA1 splice variant, c.5332+4delA
|
Yang, Ciyu
|
|
2017
|
168 |
2 |
p. 543-550
|
article
|
| 11 |
Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis
|
Underwood, E. A.
|
|
2017
|
168 |
2 |
p. 299-310
|
article
|
| 12 |
Comments on “Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors” by Parise CA and Caggiano V, Breast Cancer Res Treat, 2017.
|
Pichilingue-Febres, Alejandra F.
|
|
2017
|
168 |
2 |
p. 577-578
|
article
|
| 13 |
Correction to: Dietary intake of soy and cruciferous vegetables and treatment-related symptoms in Chinese-American and non-Hispanic White breast cancer survivors
|
Nomura, Sarah J. O.
|
|
2018
|
168 |
2 |
p. 481-482
|
article
|
| 14 |
Dietary intake of soy and cruciferous vegetables and treatment-related symptoms in Chinese-American and non-Hispanic White breast cancer survivors
|
Nomura, Sarah J. O.
|
|
2017
|
168 |
2 |
p. 467-479
|
article
|
| 15 |
Effects of physical exercise on markers of inflammation in breast cancer patients during adjuvant chemotherapy
|
Vulpen, Jonna K. van
|
|
2017
|
168 |
2 |
p. 421-431
|
article
|
| 16 |
Efficacy of palbociclib plus fulvestrant after everolimus in hormone receptor-positive metastatic breast cancer
|
du Rusquec, Pauline
|
|
2017
|
168 |
2 |
p. 559-566
|
article
|
| 17 |
Enrichment of high-grade tumors in breast cancer gene expression studies
|
Seijen, M. van
|
|
2017
|
168 |
2 |
p. 327-335
|
article
|
| 18 |
Genetic variation in TNFα, PPARγ, and IRS-1 genes, and their association with breast-cancer survival in the HEAL cohort
|
Duggan, Catherine
|
|
2017
|
168 |
2 |
p. 567-576
|
article
|
| 19 |
Impact of geriatric assessment for the therapeutic decision-making of breast cancer: results of a French survey. AFSOS and SOFOG collaborative work
|
Falandry, Claire
|
|
2017
|
168 |
2 |
p. 433-441
|
article
|
| 20 |
Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer
|
Matikas, Alexios
|
|
2017
|
168 |
2 |
p. 349-355
|
article
|
| 21 |
99mTc-rituximab as a tracer for sentinel lymph node biopsy in breast cancer patients: a single-center analysis
|
Wang, Jiwei
|
|
2017
|
168 |
2 |
p. 365-370
|
article
|
| 22 |
Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy
|
Pistilli, B.
|
|
2017
|
168 |
2 |
p. 357-364
|
article
|
| 23 |
Potential biomarkers of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer
|
Fang, Hehui
|
|
2017
|
168 |
2 |
p. 287-297
|
article
|
| 24 |
Predictors of survival for breast cancer patients with a BRCA1 mutation
|
Narod, Steven A.
|
|
2017
|
168 |
2 |
p. 513-521
|
article
|
| 25 |
PRMT5 determines the sensitivity to chemotherapeutics by governing stemness in breast cancer
|
Wang, Zhe
|
|
2017
|
168 |
2 |
p. 531-542
|
article
|
| 26 |
Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer
|
Blok, Erik J.
|
|
2017
|
168 |
2 |
p. 413-420
|
article
|
| 27 |
Trastuzumab combined with doublet or single-agent chemotherapy as first-line therapy for HER2-positive metastatic breast cancer
|
Yu, Y. F.
|
|
2017
|
168 |
2 |
p. 337-348
|
article
|
| 28 |
Trends in progression-free survival (PFS) and time to progression (TTP) over time within first-line aromatase inhibitors trials in hormone receptor-positive advanced breast cancer
|
Reinert, T.
|
|
2017
|
168 |
2 |
p. 457-465
|
article
|
| 29 |
Weak circadian rhythm increases neutropenia risk among breast cancer patients undergoing adjuvant chemotherapy
|
Li, Wentao
|
|
2017
|
168 |
2 |
p. 483-493
|
article
|
| 30 |
Worse survival after breast cancer in women with anorexia nervosa
|
Bens, Annet
|
|
2017
|
168 |
2 |
p. 495-500
|
article
|
Journal description